Violation Tracker Individual Record

Company: 
Mylan Inc.
Current Parent Company: 
Mylan
Penalty: 
$465,000,000
Primary Offense: 
False Claims Act
Violation Description: 

Mylan Inc. and Mylan Specialty L.P. agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed primarily to Medicaid.

Year: 
2017
Date: 
August 17, 2017
Agency: 
Justice Department Civil Division
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Netherlands (reincorporated for tax reasons)
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.